56th Annual Meeting of the Society for Leukocyte Biology
白细胞生物学学会第 56 届年会
基本信息
- 批准号:10752090
- 负责人:
- 金额:$ 2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-10 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAcute DiseaseAddressAutoimmunityAwardAwarenessBasic ScienceBig DataBiologyChronic DiseaseClinicClinicalCoffeeCommunitiesDevelopmentDiseaseDisparity populationDoctor of PhilosophyEducational workshopEquilibriumEquityEthnic OriginFosteringFunctional disorderFundingFutureGenderGeographyGoalsGovernmentHealthHost DefenseImmune responseImmune systemImmunityImmunologyIndustryInflammationInformation DisseminationInstructionLearningLeukocytesMalignant NeoplasmsMedicineMentorsNatural ImmunityOralPublic HealthRaceResearchResearch PersonnelRoleScientific SocietiesScientistSeminalSiteSocietiesTexasTranslatingTranslationsTravelUnderrepresented PopulationsUniversitiesWomanadaptive immunitycancer immunotherapycareercareer developmentdesigndiversity and inclusionequity, diversity, and inclusionexpectationexperienceforgingfrontierhuman diseaseinnovationinsightinterestinternational partnershipmeetingsnext generationnovelnovel therapeutic interventionpathogenic microbepathogenic viruspostersprogramssuccesssymposiumtechnological innovation
项目摘要
ABSTRACT
This proposal is to request support for the 56th Annual Meeting of the Society for Leukocyte Biology
entitled: “The Future of Immunology: New Solutions to Old Problems”. The meeting will be held September 27 –
30, 2023, at the University of Georgia Conference Center in Athens, GA. Funds derived from this proposal will
be distributed in the form of travel awards that will provide much needed assistance to young investigators and
trainees. The Organizers of the 56th annual meeting are Peter Keyel, Ph.D. (Texas Tech University) and Balázs
Rada, Ph.D. (University of Georgia).
SLB is the leading scientific society with a focus on leukocytes and their roles in the pathophysiology of
acute and chronic diseases. No other scientific meeting regarding study of the immune system focuses on the
leukocyte with the breadth and depth of SLB, so the annual meetings sponsored by SLB fill this void. Therefore,
SLB is the premier society in the field of leukocyte biology, and convenes annually to promote scientific exchange
among researchers and support the career development of trainees and junior investigators. Funds derived from
this proposal will be distributed in the form of travel awards that will provide much needed assistance to facilitate
the ability of young investigators and trainees to attend. The essential goals of the annual meeting include: 1)
advancing original research and related scientific endeavors in the field of leukocyte biology and host defense,
2) promoting the career development of junior and new investigators interested in leukocyte biology, 3)
disseminating information about the field to the wider scientific and lay audience, and 4) encouraging the
translation of basic research in leukocyte biology to applications in the clinic. These goals will be achieved
through three Aims: Aim 1: To provide an innovative and scientifically progressive program, in a collegial forum,
to address the latest developments in leukocyte biology. The agenda will include a total of 4 Plenary Sessions
and 8 Concurrent Sessions with a total of 19 invited speakers. Aim 2: To provide an opportunity for new
investigators and trainees to interact closely with established scientists. A significant innovation for recent
iterations of the annual meeting is the SLB-SCHOOL (Society for Leukocyte Biology-Symposium for Career
development and Hands-On Opportunity to Learn) which offers trainees a full day instructional workshop
covering topics related to leukocyte biology research. The expectation is that enrollees will gain practical insight
into this topic and more actively participate with experts in the field. Aim 3: To promote diversity and inclusion in
the field of leukocyte biology by cultivating the participation of women, underrepresented groups and
disadvantaged individuals. The Diversity, Equity and Inclusion (DEI) committee will sponsor workshops and
awards to encourage the participation of women and scientists from underrepresented groups. In sum, the 2023
annual meeting of SLB is purposefully designed to enhance awareness of the influence of leukocyte biology in
health and disease and inspire young investigators.
抽象的
本提案请求支持白细胞生物学学会第 56 届年会
题为:“免疫学的未来:老问题的新解决方案”。会议将于9月27日举行——
2023 年 2 月 30 日,在佐治亚州雅典市佐治亚大学会议中心。从该提案中获得的资金将
以旅行奖励的形式分发,这将为年轻调查人员提供急需的帮助
实习生。第 56 届年会的组织者是 Peter Keyel 博士。 (德克萨斯理工大学)和巴拉兹
拉达博士(佐治亚大学)。
SLB 是领先的科学协会,专注于白细胞及其在疾病病理生理学中的作用
急性和慢性疾病。没有其他关于免疫系统研究的科学会议关注
白细胞具有SLB的广度和深度,因此SLB主办的年会填补了这一空白。所以,
SLB 是白细胞生物学领域的首要学会,每年召开一次会议以促进科学交流
并支持实习生和初级研究员的职业发展。资金来源于
该提案将以旅行奖励的形式分发,这将提供急需的援助,以促进
年轻研究者和受训人员参加的能力。年会的基本目标包括:1)
推进白细胞生物学和宿主防御领域的原创研究和相关科学努力,
2) 促进对白细胞生物学感兴趣的初级和新研究者的职业发展,3)
向更广泛的科学界和非专业受众传播有关该领域的信息,以及4)鼓励
将白细胞生物学的基础研究转化为临床应用。这些目标将会实现
通过三个目标: 目标 1:在学院论坛中提供创新和科学进步的计划,
解决白细胞生物学的最新发展。议程共包括4场全体会议
8场同期会议,共19位特邀演讲嘉宾。目标2:为新人提供机会
研究人员和受训人员与知名科学家密切互动。最近的一项重大创新
年会的迭代是SLB-SCHOOL(白细胞生物学学会-职业研讨会)
开发和实践学习机会),为学员提供全天的教学研讨会
涵盖与白细胞生物学研究相关的主题。期望参与者能够获得实用的见解
深入研究这个话题,并更积极地与该领域的专家一起参与。目标 3:促进多元化和包容性
通过培养妇女、代表性不足的群体和群体的参与来发展白细胞生物学领域
弱势个体。多元化、公平和包容性 (DEI) 委员会将赞助研讨会和
奖励以鼓励来自代表性不足群体的妇女和科学家的参与。总而言之,2023
SLB年会的目的是提高人们对白细胞生物学影响的认识
健康与疾病并激励年轻的研究人员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CRAIG THOMAS LEFORT其他文献
CRAIG THOMAS LEFORT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CRAIG THOMAS LEFORT', 18)}}的其他基金
Selective Modulation of Neutrophils in Critical Illness
危重疾病中中性粒细胞的选择性调节
- 批准号:
10551956 - 财政年份:2017
- 资助金额:
$ 2万 - 项目类别:
Selective modulation of neutrophils in critical illness
危重疾病中中性粒细胞的选择性调节
- 批准号:
9750019 - 财政年份:2017
- 资助金额:
$ 2万 - 项目类别:
A murine model of Pseudomonas aeruginosa pneumonia secondary to hemorrhagic shock
失血性休克继发铜绿假单胞菌肺炎小鼠模型
- 批准号:
9294349 - 财政年份:2017
- 资助金额:
$ 2万 - 项目类别:
Selective modulation of neutrophils in critical illness
危重疾病中中性粒细胞的选择性调节
- 批准号:
9382234 - 财政年份:2017
- 资助金额:
$ 2万 - 项目类别:
Selective modulation of neutrophils in critical illness
危重疾病中中性粒细胞的选择性调节
- 批准号:
10220991 - 财政年份:2017
- 资助金额:
$ 2万 - 项目类别:
相似海外基金
Improving Acute Disease Management for Patients with Alzheimer's Disease and Related Dementias
改善阿尔茨海默病和相关痴呆症患者的急性疾病管理
- 批准号:
10712647 - 财政年份:2001
- 资助金额:
$ 2万 - 项目类别:
INDUCTION OF ACUTE DISEASE IN MACAQUES BY NEF GENE VARIANT OF SIVMAC239
SIVMAC239 的 NEF 基因变体在猕猴中诱导急性疾病
- 批准号:
6247642 - 财政年份:1997
- 资助金额:
$ 2万 - 项目类别:
INDUCTION OF ACUTE DISEASE IN MACAQUES BY NEF GENE VARIANT OF SIVMAC239
SIVMAC239 的 NEF 基因变体在猕猴中诱导急性疾病
- 批准号:
3718999 - 财政年份:
- 资助金额:
$ 2万 - 项目类别:
Neurophysiological alterations in multiple sclerosis patients during acute disease acivity
多发性硬化症患者急性疾病活动期间的神经生理学变化
- 批准号:
465668867 - 财政年份:
- 资助金额:
$ 2万 - 项目类别:
Research Grants
SIVMAC 1NEF ALLELE: LYMPHOCYTE ACTIVATION & ACUTE DISEASE IN MACAQUE MONKEYS
SIVMAC 1NEF 等位基因:淋巴细胞激活
- 批准号:
3719026 - 财政年份:
- 资助金额:
$ 2万 - 项目类别:














{{item.name}}会员




